التفاصيل البيبلوغرافية
العنوان: |
Chemokine Receptor 2-targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial. |
المؤلفون: |
Brody, Steven L., Gunsten, Sean P., Luehmann, Hannah P., Sultan, Debbie H., Hoelscher, Michelle, Gyu Seong Heo, Jiehong Pan, Koenitzer, Jeffrey R., Lee, Ethan C., Tao Huang, Mpoy, Cedric, Shuchi Guo, Laforest, Richard, Salter, Amber, Russell, Tonya D., Shifren, Adrian, Combadiere, Christophe, Lavine, Kory J., Kreisel, Daniel, Humphreys, Benjamin D. |
المصدر: |
American Journal of Respiratory & Critical Care Medicine; 1/1/2021, Vol. 203 Issue 1, p78-89, 12p |
مصطلحات موضوعية: |
CHEMOKINE receptors, IDIOPATHIC pulmonary fibrosis, POSITRON emission tomography, MACROPHAGES, MONOCYTES, BIOLOGICAL models, MOLECULAR diagnosis, LUNGS, ANIMAL experimentation, CELL receptors, DIAGNOSTIC imaging, MICE |
مستخلص: |
Rationale: Idiopathic pulmonary fibrosis (IPF) is a progressive inflammatory lung disease without effective molecular markers of disease activity or treatment responses. Monocyte and interstitial macrophages that express the C-C motif CCR2 (chemokine receptor 2) are active in IPF and central to fibrosis.Objectives: To phenotype patients with IPF for potential targeted therapy, we developed 64Cu-DOTA-ECL1i, a radiotracer to noninvasively track CCR2+ monocytes and macrophages using positron emission tomography (PET).Methods: CCR2+ cells were investigated in mice with bleomycin- or radiation-induced fibrosis and in human subjects with IPF. The CCR2+ cell populations were localized relative to fibrotic regions in lung tissue and characterized using immunolocalization, single-cell mass cytometry, and Ccr2 RNA in situ hybridization and then correlated with parallel quantitation of lung uptake by 64Cu-DOTA-ECL1i PET.Measurements and Main Results: Mouse models established that increased 64Cu-DOTA-ECL1i PET uptake in the lung correlates with CCR2+ cell infiltration associated with fibrosis (n = 72). As therapeutic models, the inhibition of fibrosis by IL-1β blockade (n = 19) or antifibrotic pirfenidone (n = 18) reduced CCR2+ macrophage accumulation and uptake of the radiotracer in mouse lungs. In lung tissues from patients with IPF, CCR2+ cells concentrated in perifibrotic regions and correlated with radiotracer localization (n = 21). Human imaging revealed little lung uptake in healthy volunteers (n = 7), whereas subjects with IPF (n = 4) exhibited intensive signals in fibrotic zones.Conclusions: These findings support a role for imaging CCR2+ cells within the fibrogenic niche in IPF to provide a molecular target for personalized therapy and monitoring.Clinical trial registered with www.clinicaltrials.gov (NCT03492762). [ABSTRACT FROM AUTHOR] |
|
Copyright of American Journal of Respiratory & Critical Care Medicine is the property of American Thoracic Society and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
قاعدة البيانات: |
Complementary Index |